Sean Bohen

Biography

He is the Executive Vice-President and Chief Medical Officer of AstraZeneca AB Company. He served as a Senior Medical Officer of AstraZeneca AB Company. He is a recipient of many awards and grants for his valuable contributions in his field of Global Medicines Development. He is at the Editorial Board Member of many peer reviewed journals and as his area of expertise credits of Advisory Board of Marketing with many publications in national and international journals. Sean was appointed Executive Vice-President, GMD in September 2015 and leads our global late-stage development organisation for both small molecules and biologics. He is also the Company’s Chief Medical Officer and is responsible for patient safety across the entire AstraZeneca and MedImmune portfolio. He joined AstraZeneca from Genentech, where he held a number of senior leadership roles across various therapy areas and was most recently Senior Vice President of Early Development. Before joining Genentech, Sean was a Clinical Instructor in Oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the National Cancer Institute. He is a graduate of the University of Wisconsin and later earned his doctorate in biochemistry and his medical degree at the University of California, San Francisco.

Research Interest

Medical Development